More Globe Newswire

View Older Stories View Newer Stories

Mar 24, 2025 07:30AM BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Session

Mar 24, 2025 07:29AM Dimensional Fund Advisors Ltd. : Form 8.3 - DALATA HOTEL GROUP PLC - Ordinary Shares

Mar 24, 2025 07:29AM Intuitive Machines Reports Fourth Quarter and Full-Year 2024 Financial Results

Mar 24, 2025 07:25AM AGF Investments Announces March 2025 Cash Distributions for Certain AGF ETFs and ETF Series

Mar 24, 2025 07:11AM PolarFire® SoC FPGAs Achieve AEC-Q100 Qualification

Mar 24, 2025 07:08AM MGA Entertainment Hops into Spring with a Sweet New Lineup of Seasonal Toys in Time for Spring and Easter Gifting

Mar 24, 2025 07:05AM Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Mar 24, 2025 07:05AM Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call 

Mar 24, 2025 07:05AM Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 24, 2025 07:05AM Kraig Biocraft Laboratories Sets New World Record for Largest Spider Silk Gene Insert into Silkworm

Mar 24, 2025 07:01AM UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema

Mar 24, 2025 07:00AM Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024

Mar 24, 2025 07:00AM Arsen Introduces AI-Powered Phishing Tests to Improve Social Engineering Resilience

Mar 24, 2025 07:00AM How CNH’s precision technology is helping farmers tackle water scarcity

Mar 24, 2025 07:00AM Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025 07:00AM Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Mar 24, 2025 07:00AM Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

Mar 24, 2025 07:00AM Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services

Mar 24, 2025 07:00AM Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders

Mar 24, 2025 07:00AM Transpire Delivers AI-Assisted Story Building with Case Concepts

Mar 24, 2025 07:00AM Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.

Mar 24, 2025 07:00AM Tilray Wellness Collaborates with Whole Foods Market to Relaunch Hi*Ball Energy Drinks into National US Retail

Mar 24, 2025 07:00AM MAG Silver Reports 2024 Annual Financial Results

Mar 24, 2025 07:00AM Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value

Mar 24, 2025 07:00AM Next Hydrogen Announces Strategic Partnership with Sungrow Hydrogen

Mar 24, 2025 07:00AM Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

Mar 24, 2025 07:00AM Dogecoin Cash, Inc. Subsidiary MEME Coins Inc. Acquires 1 Billion DOG Tokens from Tipestry, Inc.

Mar 24, 2025 07:00AM Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates

Mar 24, 2025 07:00AM Rapid7 Appoints Three New Board Members

Mar 24, 2025 07:00AM ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference

Mar 24, 2025 07:00AM Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular

Mar 24, 2025 07:00AM Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Sin

Mar 24, 2025 07:00AM Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer

Mar 24, 2025 07:00AM Heineken N.V. reports the progress of transactions under its current share buyback programme

Mar 24, 2025 07:00AM Transactions in connection with share buyback programme

Mar 24, 2025 07:00AM Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round

Mar 24, 2025 06:59AM Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference

Mar 24, 2025 06:51AM Man Group PLC : Form 8.3 - Dowlais Group plc

Mar 24, 2025 06:48AM Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings Inc

Mar 24, 2025 06:46AM Aller Media expands Agillic across the Nordics

Mar 24, 2025 06:45AM Man Group PLC : Form 8.3 - Serica Energy plc

Mar 24, 2025 06:45AM MAG Announces Dividend Policy and Inaugural Dividend

Mar 24, 2025 06:45AM Brazil Potash Awards Vegetation Management Contract for Autazes Project Site Preparation

Mar 24, 2025 06:43AM Man Group PLC : Form 8.3 - Dalata Hotel Group plc

Mar 24, 2025 06:38AM HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc

Mar 24, 2025 06:35AM Montage Gold Achieves Key Construction Milestone at Its Koné Project as Process Plant Concrete Works Commenced

Mar 24, 2025 06:30AM Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Mar 24, 2025 06:27AM UTStarcom Reports Unaudited Financial Results for Second Half and Full Year 2024

Mar 24, 2025 06:26AM XploraDEX Aims to Transform How Liquidity Works on The XRP Ledger – $XPL Token Presale Now Open!

Mar 24, 2025 06:10AM Intermediate Capital Group plc: Notification of Major Holdings (Correction)

View Newer Stories View Older Stories